Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease.

Source:http://linkedlifedata.com/resource/pubmed/id/21320138

Download in:

View as

General Info

PMID
21320138